Published April 2006 | Version v1
Journal article

Inhibition of serotonin transport by (+)McN5652 is noncompetitive

  • 1. Biochemical Laboratory, Central Institute of Mental Health, 68159 Mannheim (Germany)
  • 2. Department of Nuclear Medicine, University Medical Center Hamburg-Eppendorf, D-20246 Hamburg (Germany)
  • 3. Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, D-20246 Hamburg (Germany)
  • 4. Department of Nuclear Medicine, University Hospital Tuebingen, D-72076 Tuebingen (Germany)

Description

Introduction: Imaging of the serotonergic innervation of the brain using positron emission tomography (PET) with the serotonin transporter (SERT) ligand [11C] (+)McN5652 might be affected by serotonin in the synaptic cleft if there is relevant interaction between [11C] (+)McN5652 and serotonin at the SERT. The aim of the present study therefore was to pharmacologically characterize the interaction of [11C] (+)McN5652 and serotonin at the SERT. Methods: In vitro saturation analyses of [3H]serotonin uptake into HEK293 cells stably expressing the human SERT were performed in the absence and presence of unlabelled (+)McN5652. Data were evaluated assuming Michaelis-Menten kinetics. Results: Unlabelled (+)McN5652 significantly reduced the maximal rate of serotonin transport V max of SERT without affecting the Michaelis-Menten constant K M. Conclusions: This finding indicates that (+)McN5652 inhibits serotonin transport through the SERT in a noncompetitive manner. This might suggest that [11C] (+)McN5652 PET is not significantly affected by endogenous serotonin

Additional details

Identifiers

DOI
10.1016/j.nucmedbio.2005.12.009;
PII
S0969-8051(05)00305-7;

Publishing Information

Journal Title
Nuclear Medicine and Biology
Journal Volume
33
Journal Issue
3
Journal Page Range
p. 317-323
ISSN
0969-8051
CODEN
NMBIEO

Optional Information

Copyright
Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.